bharat biotech's boss defends covaxin
Published 3 years ago • 1.7K plays • Length 3:18Download video MP4
Download video MP3
Similar videos
-
1:21
bharat biotech’s covaxin's phase 3 trial data looks good: who chief scientist
-
1:17
covaxin, bharat biotech's coronavirus vaccine, cleared for phase 3 trials
-
5:32
covaxin maker bharat biotech's nasal booster dose trials get approval
-
1:16
bharat biotech to provide 55 lakh covaxin doses at rs 295 per dose
-
0:50
bharat biotech’s intranasal covid vaccine has been approved by government as booster dose for adults
-
1:22
india's first covid vaccines: dcgi approves oxford vaccine and bharat biotech's covaxin
-
5:41
trump 2.0 | yoga guru ramdev on trump’s victory: a new era of nationalism & india-u.s. relations
-
11:42
top 10 questions asked in biotech interview how to answer them?
-
1:07
delhi under dense fog
-
1:33
bharat biotech may launch covaxin in q2 2021
-
0:53
bharat biotech intranasal vaccine priced at rs 325
-
0:59
incovacc - india's first intranasal covid vaccine by bharat biotech
-
9:08
covid vaccine approval row: bharat biotech defends covaxin after backlash over lack of data
-
0:56
delegates visited bharat biotech's genome valley plant during the visit
-
4:15
coronavirus vaccine| bharat biotech's top brass slams covaxin critics| covid-19 news | covid vaccine
-
0:48
covaxin gets dcgi eua nod #shorts
-
3:11
covid vaccine approval row: bharat biotech aggressively defends covaxin
-
0:20
bharat biotech denies any wrongdoing amid row over brazil covaxin deal
-
0:41
'uk strain is a whole virus but bharat biotech vaccine can have edge': director general of icmr
-
0:51
fauci: covaxin found to neutralise the 617 variant found in india
-
0:42
#shorts | amid bf.7 #covid scare, india approves bharat biotech's nasal vaccine
-
0:27
‘inadvertent mistake,’ says bharat biotech on why it failed to credit icmr in covaxin patent filings